Treat-to-Target Serum Urate Versus Treat-to-Avoid Symptoms in Gout
Clinical trial NCT04875702 · RECRUITING
Trial details
- NCT number
- NCT04875702
- Sponsor
- Massachusetts General Hospital
- Status
- RECRUITING
- Phase
- Phase 4
- Study type
- INTERVENTIONAL
- Start date
- 2024-02-22
- Primary completion
- 2028-09-01
- Enrollment
- 650
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.